Christine Dingivan, M.D. has been appointed executive vice president and chief medical officer, PPD, Inc. Dr. Dingivan provides strategic direction for global regulatory affairs and pharmacovigilance, biomarker discovery sciences, Phase I, and bioanalytical and cGMP lab services. She is also responsible for medical assessment of clinical data as well as adherence to ethical standards and good lab practices.     Prior to joining the company, Dr. Dingivan spent 12 years with MedImmune, which wa...